GlobeImmune presents GI-4000 Phase 2 NSCLC data at IASLC Continue reading
October 27, 2013
Monthly Archives: October 2013
October 15, 2013
GlobeImmune Announces Milestone Payment for Initiation of Phase 2 Clinical Trial for GS-4774 (Formerly GI-13020) Continue reading